| # | Drug | Count |
|---|---|---|
| 0 | CAPLACIZUMAB | 161 |
| 1 | RITUXIMAB | 45 |
| 2 | METHYLPREDNISOLONE | 19 |
| 3 | ACETAMINOPHEN | 15 |
| 4 | ACETAMINOPHEN 500MG | 13 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 13 |
| 6 | PAIN RELIEVER | 13 |
| 7 | PREDNISONE | 13 |
| 8 | AMLODIPINE | 12 |
| 9 | ASPIRIN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 161 | 0.0902 |
| 1 | CEFPROZIL | 2 | 0.0026 |
| 2 | CEFOTAXIME INJECTION | 6 | 0.0014 |
| 3 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 4 | TENECTEPLASE | 1 | 0.0006 |
| 5 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 6 | ZIDOVUDINE | 6 | 0.0006 |
| 7 | GANCICLOVIR SODIUM | 6 | 0.0006 |
| 8 | OFLOXACIN | 3 | 0.0004 |
| 9 | AMPHOTERICIN B | 5 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 2 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 3 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 4 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 45 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Glycopeptide Antibacterial [EPC] | 7 | 0.0001 |